Monovisc

Monovisc is an orthopaedic injection and a leading choice for healthcare providers and aesthetic practitioners who seek an effective solution for joint pain relief.

Available from reputable suppliers like Nu Derma Supply, Monovisc is designed for those seeking optimal results in patient care.

Medical professionals can buy Monovisc injections online from authorised sources to ensure authenticity and efficacy, making it a trusted product in the field of orthopaedics and joint care.

Sort Products

Buy Monovisc Online: The Ultimate Solution for Osteoarthritis Relief

Monovisc is a leading brand in osteoarthritis treatment, renowned for its innovative approach to pain management.

Developed by Anika Therapeutics, Monovisc offers a single-injection solution that utilises hyaluronic acid to restore joint lubrication and alleviate discomfort.

Trusted by orthopaedic specialists, Monovisc has become synonymous with quality and efficacy in joint health therapy.

What Is Monovisc?

Monovisc is a single orthopaedic injection treatment based on hyaluronic acid and specifically designed to relieve pain in patients with osteoarthritis of the knee.

It works by supplementing the synovial fluid in the joint, restoring its natural lubrication and cushioning properties. This helps reduce pain, improve mobility, and slow down the progression of osteoarthritis.

Monovisc is unique because it provides relief with just one injection, unlike other hyaluronic acid products that require a series of injections.

The main ingredient in Monovisc is cross-linked hyaluronic acid (88 mg), which mimics the natural substance found in healthy joints. This cross-linking technology enhances the durability of the product, allowing it to provide long-lasting relief.

Explore the Nu Derma Supply catalogue to buy Monovisc online from a trusted distributor that guarantees the highest quality and product integrity.

What Is Monovisc Used for?

Monovisc is primarily used to alleviate pain and discomfort in osteoarthritis patients. It can be injected into the following areas:

  • Knee joints: The primary target area for osteoarthritis pain relief, Monovisc lubricates the knee, reducing friction and inflammation.
  • Other joints: Although its primary use is for knees, healthcare professionals may administer Monovisc to other joints affected by osteoarthritis, such as shoulders, hips, and ankles.

Who Is the Manufacturer of Monovisc Injections?

Monovisc is manufactured by Anika Therapeutics, Inc., a biotechnology company based in Massachusetts, USA.

Established in 1983, Anika Therapeutics has become a global leader in the development, manufacturing, and commercialisation of therapeutic products for tissue protection, healing, and repair.

Monovisc Main Ingredients

Monovisc contains key components that make it safe and efficient in knee pain relief, including:

  • Hyaluronic acid: It is naturally found in synovial fluid, providing lubrication and shock absorption. In Monovisc, this acid is cross-linked to enhance its longevity and effectiveness in treating joint pain.
  • Sodium chloride: Maintains the osmotic balance within the solution.
  • Sodium phosphate: Used as a buffering agent to stabilise the pH of the injection.
  • Water for injection: Ensures the solution is free from impurities and safe for administration.

Is Monovisc the Same as Hyaluronic Acid?

Yes, Monovisc is a hyaluronic acid-based product that provides sustained joint lubrication and pain relief.

The hyaluronic acid in Monovisc is cross-linked, making it more durable and longer-lasting than regular, non-cross-linked hyaluronic acid.

Who Can Administer Monovisc?

Monovisc must be administered by a licensed healthcare professional with training and experience in joint injections. Orthopaedic surgeons, rheumatologists, and general practitioners specialising in musculoskeletal conditions are commonly qualified to administer Monovisc.

While registered nurses with specialised training may also perform the injections under physician supervision, the procedure should always be conducted in a clinical setting to ensure safety.

How Is Monovisc Administered?

Monovisc is administered as an intra-articular injection directly into the affected joint. The procedure is as follows:

  • The patient is positioned to allow easy access to the joint.
  • The injection site is cleaned and sterilised with an antiseptic solution.
  • A local anaesthetic may be applied to minimise discomfort.
  • The healthcare provider injects Monovisc into the joint using a sterile syringe.
  • After the injection, the patient is advised to rest the joint for a few hours and monitor for any adverse reactions.

Product Range

Monovisc is available in a 4 mL syringe containing 88 mg of cross-linked hyaluronic acid. It is a single-dose treatment, designed to provide relief from osteoarthritis pain with just one injection.

Benefits and Results of Using Monovisc Injections

Monovisc offers several key benefits for osteoarthritis patients:

  • Single injection treatment: Provides long-lasting relief with just one injection, reducing the need for repeated visits.
  • Effective pain relief: Reduces joint pain, allowing patients to move more freely.
  • Restores joint function: Improves joint lubrication, making movement smoother and less painful.
  • Non-surgical solution: Offers a non-invasive option for patients who want to delay or avoid surgery.
  • Minimal side effects: Most patients experience little to no side effects from Monovisc.

How Long Do Monovisc Results Last?

The effects of Monovisc can last up to six months, depending on the severity of osteoarthritis and the patient’s individual response to treatment. Some patients may experience relief for a shorter or longer period.

Recommendations Before and After the Treatment

To ensure optimal results from Monovisc injections, patients should follow these guidelines:

Before treatment

  • Inform the healthcare provider of any allergies or medical conditions.
  • Avoid taking anti-inflammatory medications for at least 48 hours prior to the injection.
  • Ensure the joint is free of infection or inflammation.

 

After treatment

  • Rest the injected joint for at least 24-48 hours.
  • Avoid strenuous activities or high-impact exercises for at least 48 hours.
  • Monitor for any signs of infection, such as swelling, redness, or warmth at the injection site.
  • Apply ice to the injection site if there is mild pain or swelling.

What Do Monovisc Injection Reviews Say?

Many patients report significant pain relief within a few weeks of the injection, with improved mobility and joint function.

Medical professionals often highlight the convenience of the single-dose injection, which reduces the need for multiple appointments and offers sustained relief.

Some reviews also mention that Monovisc helps patients delay more invasive procedures, such as joint replacement surgery, by providing effective pain management.

Potential Monovisc Injection Side Effects

Monovisc generally has a good safety profile, but some patients may experience side effects, including:

  • Mild pain at the injection site: Common but typically resolves within a few days.
  • Swelling: Localised swelling may occur after the injection.
  • Joint stiffness: Some patients experience temporary stiffness in the injected joint.
  • Allergic reactions: Rare but possible, including symptoms like itching, swelling, or hives.
  • Infection: Very rare, but any signs of infection should be reported immediately.

Contraindications for the Treatment

Certain patients may not be candidates for Monovisc treatment. The following contraindications should be considered:

  • Allergy to hyaluronic acid: Patients with a known allergy should not receive Monovisc.
  • Infection in the joint: Active infections must be treated before administering Monovisc.
  • Bleeding disorders: Patients with clotting disorders or on anticoagulants should exercise caution.
  • Pregnancy and breastfeeding: The safety of Monovisc during pregnancy or breastfeeding has not been established.
  • Severe osteoarthritis: In some cases, Monovisc may not be effective for patients with very severe osteoarthritis.
  • Joint instability: If the joint is significantly unstable, Monovisc may not be able to provide lasting relief.
  • Previous unsuccessful treatments: Patients who have not responded well to other treatments for osteoarthritis may also be less likely to benefit from Monovisc.

Who Can Buy Monovisc Products and Where?

Orthopaedic surgeons, rheumatologists, and other qualified healthcare providers can buy Monovisc from authorised and trusted suppliers like Nu Derma Supply to ensure product authenticity and patient safety.

What Is Monovisc Injection Price in the UK?

In the UK, Monovisc injections typically cost between £250 and £350 per 4 mL syringe, depending on the supplier and any promotions available.

What Is Monovisc Injection Price in the Philippines?

In the Philippines, Monovisc is priced between PHP 18,000 and PHP 25,000 for a single 4 mL syringe, depending on the clinic and availability.

FAQ

1. Is Monovisc injection a steroid?

No, Monovisc is not a steroid. It is a hyaluronic acid-based product that mimics the natural substance found in joints to provide lubrication and pain relief.

2. How does Monovisc work?

Monovisc works by supplementing the synovial fluid in the joint, improving lubrication and cushioning. This reduces pain, improves mobility, and helps protect the joint from further wear and tear.

3. How long does it take for Monovisc to start working?

Many patients start to notice relief within one to two weeks after the injection, with full benefits typically felt after three to four weeks.

4. Is Monovisc a one-time injection?

Yes, Monovisc is designed as a single injection treatment that provides relief for up to six months, although some patients may require additional injections later.

5. What is the difference between Monovisc and Durolane?

Both Monovisc and Durolane are hyaluronic acid-based injections, but Monovisc is administered as a single 4 mL injection, while Durolane is available in different formulations and is used more broadly for various joints.

6. Is Synvisc better than Monovisc?

Both Synvisc and Monovisc are effective treatments for osteoarthritis. However, Synvisc typically requires multiple injections, while Monovisc provides relief with just one injection. The choice depends on patient preference and the recommendation of the healthcare provider.